Bade Miyan Chote Miyan is an exciting action film directed by Ali Abbas Zafar. The movie features Akshay Kumar and Tiger Shroff in lead roles, with Prithviraj Sukumaran as the antagonist. Sonakshi, Alaya F, and Manushi also play key parts.
The plot follows two contrasting characters, Bade Miyan and Chote Miyan, who come together to fight a masked foe endangering national security. Their mission is packed with thrilling action scenes shot in places like Scotland and London.
Bade Miyan Chote Miyan is an action-filled film featuring Akshay Kumar and Tiger Shroff. Directed by Ali Abbas Zafar, it showcases exciting action sequences shot in locations such as Scotland and Abu Dhabi. The chemistry between the lead actors is a highlight.
However, critics argue that the nonstop action, while impressive, can feel repetitive and exhausting. Supporting roles by Sonakshi Sinha and Prithviraj Sukumaran add little to the story. The film also suffers from pacing problems and weak dialogue, which diminish its overall effect.
Main Actors
Akshay Kumar as Bade Miyan / Firoz / Freddy
Tiger Shroff as Chote Miyan / Rakesh / Rocky
Prithviraj Sukumaran as Kabir / Dr. Kabir / Eklavya
Sonakshi Sinha as Captain Priya Dixit
Manushi Chhillar as Captain Misha Kapoor
Alaya F as IT Specialist Dr. Parminder Bawa Pam
Ronit Roy as Colonel Adil Shekhar Azad
Story
Bade Miyan Chote Miyan is an exciting film featuring a thrilling story about a masked villain who takes the country's most dangerous weapon. Colonel Azad tasks his best officer with uniting two famous soldiers from his team: the serious Bade Miyan and the self-assured Chote Miyan.
Box Office
Bade Miyan Chote Miyan had a mixed reaction at the box office. Even with a star-studded cast and high hopes, the film did not do as well as expected. In its opening week, it made around ₹49.25 crores in India and a total of ₹86.50 crores globally.
The film earned about ₹27 crores from international markets and around ₹59.50 crores in India. With a budget over ₹300 crores, its box office results have been underwhelming. Experts worry it might not make back its costs.
